Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

Seremet et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69dea71e6bae133e7de947b9 — DOI: https://doi.org/10.1186/s12967-019-2051-8

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?· 2017 · 62 citations
2. Cancer DNA in the Circulation· 2017 · 93 citations
3. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies· 2014 · 5,060 citations
4. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma· 2010 · 15,102 citations
5. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma· 2015 · 8,109 citations